Teladoc Health reported a year-over-year narrower Q1 loss and revenue above estimates, helped by international growth and cost cuts. Offsetting the beat, BetterHelp weakness and subscription declines remain pressure points. The update is modestly positive for the stock, though the underlying consumer subscription trend is still soft.
Teladoc Health reported a year-over-year narrower Q1 loss and revenue above estimates, helped by international growth and cost cuts. Offsetting the beat, BetterHelp weakness and subscription declines remain pressure points. The update is modestly positive for the stock, though the underlying consumer subscription trend is still soft.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
